<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32868812</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Aug</Month><Day>31</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Functional skeletal muscle model derived from SOD1-mutant ALS patient iPSCs recapitulates hallmarks of disease progression.</ArticleTitle><Pagination><StartPage>14302</StartPage><MedlinePgn>14302</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">14302</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-020-70510-3</ELocationID><Abstract><AbstractText>Recent findings suggest a pathologic role of skeletal muscle in amyotrophic lateral sclerosis (ALS) onset and progression. However, the exact mechanism by which this occurs remains elusive due to limited human-based studies. To this end, phenotypic ALS skeletal muscle models were developed from induced pluripotent stem cells (iPSCs) derived from healthy individuals (WT) and ALS patients harboring mutations in the superoxide dismutase 1 (SOD1) gene. Although proliferative, SOD1 myoblasts demonstrated delayed and reduced fusion efficiency compared to WT. Additionally, SOD1 myotubes exhibited significantly reduced length and cross-section. Also, SOD1 myotubes had loosely arranged myosin heavy chain and reduced acetylcholine receptor expression per immunocytochemical analysis. Functional analysis indicated considerably reduced contractile force and synchrony in SOD1 myotubes. Mitochondrial assessment indicated reduced inner mitochondrial membrane potential (&#x394;&#x3a8;m) and metabolic plasticity in the SOD1-iPSC derived myotubes. This work presents the first well-characterized in vitro iPSC-derived muscle model that demonstrates SOD1 toxicity effects on human muscle regeneration, contractility and metabolic function in ALS. Current findings align with previous ALS patient biopsy studies and suggest an active contribution of skeletal muscle in NMJ dysfunction. Further, the results validate this model as a human-relevant platform for ALS research and drug discovery studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Badu-Mensah</LastName><ForeName>Agnes</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>NanoScience Technology Center, University of Central Florida, 12424 Research Parkway, Suite 400, Orlando, FL, 32826, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL, 32816, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Xiufang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>NanoScience Technology Center, University of Central Florida, 12424 Research Parkway, Suite 400, Orlando, FL, 32826, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McAleer</LastName><ForeName>Christopher W</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Hesperos Inc., 12501 Research Pkwy, Suite 100, Orlando, FL, 32826, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rumsey</LastName><ForeName>John W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Hesperos Inc., 12501 Research Pkwy, Suite 100, Orlando, FL, 32826, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hickman</LastName><ForeName>James J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>NanoScience Technology Center, University of Central Florida, 12424 Research Parkway, Suite 400, Orlando, FL, 32826, USA. jhickman@ucf.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hesperos Inc., 12501 Research Pkwy, Suite 100, Orlando, FL, 32826, USA. jhickman@ucf.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01NS050452</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019070" MajorTopicYN="N">Cell Lineage</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="N">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008931" MajorTopicYN="N">Mitochondria, Muscle</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018485" MajorTopicYN="N">Muscle Fibers, Skeletal</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D032446" MajorTopicYN="N">Myoblasts</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors confirm that competing financial interests exist but there has been no financial support for this research that could have influenced its outcome. The only author with competing interest is J.J.H. who has ownership interest and is Chief Scientist and member of the Board of Directors in a company that may benefit financially as a result of the outcomes of the research or work reported in this publication.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32868812</ArticleId><ArticleId IdType="pmc">PMC7459299</ArticleId><ArticleId IdType="doi">10.1038/s41598-020-70510-3</ArticleId><ArticleId IdType="pii">10.1038/s41598-020-70510-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tsitkanou S, Della Gatta PA, Russell AP. Skeletal muscle satellite cells, mitochondria, and microRNAs: their involvement in the pathogenesis of ALS. Front. Physiol. 2016;7:403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5020084</ArticleId><ArticleId IdType="pubmed">27679581</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P, Brown RH. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 2006;7:710.</Citation><ArticleIdList><ArticleId IdType="pubmed">16924260</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappello V, Francolini M. Neuromuscular junction dismantling in amyotrophic lateral sclerosis. Int. J. Mol. Sci. 2017;18:E2092. doi: 10.3390/ijms18102092.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18102092</ArticleId><ArticleId IdType="pmc">PMC5666774</ArticleId><ArticleId IdType="pubmed">28972545</ArticleId></ArticleIdList></Reference><Reference><Citation>Echaniz-Laguna A, et al. Muscular mitochondrial function in amyotrophic lateral sclerosis is progressively altered as the disease develops: a temporal study in man. Exp. Neurol. 2006;198:25&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">16126198</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 2004;185:232&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey D, et al. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J. Neurosci. 2000;20:2534&#x2013;2542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772256</ArticleId><ArticleId IdType="pubmed">10729333</ArticleId></ArticleIdList></Reference><Reference><Citation>Campanari ML, Bourefis AR, Kabashi E. Diagnostic challenge and neuromuscular junction contribution to ALS pathogenesis. Front. Neurol. 2019;10:68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6372519</ArticleId><ArticleId IdType="pubmed">30787905</ArticleId></ArticleIdList></Reference><Reference><Citation>Martineau E, Di Polo A, Velde CV, Robitaille R. Dynamic neuromuscular remodeling precedes motor-unit loss in a mouse model of ALS. Elife. 2018;7:e41973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6234026</ArticleId><ArticleId IdType="pubmed">30320556</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould TW, et al. Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J. Neurosci. 2006;26:8774&#x2013;8786.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6674380</ArticleId><ArticleId IdType="pubmed">16928866</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J, Comley LH, Hedlund EJA. Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:863&#x2013;885.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5427160</ArticleId><ArticleId IdType="pubmed">28409282</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S, et al. Onset and progression in inherited ALS determined by motor neurons and microglia. Annu. Rev. Neurosci. 2006;312:1389&#x2013;1392.</Citation><ArticleIdList><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Loeffler JP, Picchiarelli G, Dupuis L, Gonzalez De Aguilar JL. The role of skeletal muscle in amyotrophic lateral sclerosis. Brain Pathol. 2016;26:227&#x2013;236.</Citation><ArticleIdList><ArticleId IdType="pubmed">26780251</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 2008;11:251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen L, J&#xf8;rgensen LH, Bech RD, Frandsen U, Schr&#xf8;der HD. Skeletal muscle remodelling as a function of disease progression in amyotrophic lateral sclerosis. BioMed. Res. Int. 2016;2016:5930621.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4852332</ArticleId><ArticleId IdType="pubmed">27195289</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong M, Martin LJ. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum. Mol. Gen. 2010;19:2284&#x2013;2302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2865380</ArticleId><ArticleId IdType="pubmed">20223753</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks KJ, Hill MD, Hockings PD, Reid DG. MRI detects early hindlimb muscle atrophy in Gly93Ala superoxide dismutase-1 (G93A SOD1) transgenic mice, an animal model of familial amyotrophic lateral sclerosis. NMR Biomed. 2004;17:28&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">15011248</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcuzzo S, et al. Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: a longitudinal MRI study. Exp. Neurol. 2011;231:30&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">21620832</ArticleId></ArticleIdList></Reference><Reference><Citation>DeLoach A, Cozart M, Kiaei A, Kiaei M. A retrospective review of the progress in amyotrophic lateral sclerosis drug discovery over the last decade and a look at the latest strategies. Expert Opin. Drug Discov. 2015;10:1099&#x2013;1118.</Citation><ArticleIdList><ArticleId IdType="pubmed">26307158</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat P-F, et al. Abnormalities of satellite cells function in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2011;12:264&#x2013;271.</Citation><ArticleIdList><ArticleId IdType="pubmed">21473708</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaramozza A, et al. Skeletal muscle satellite cells in amyotrophic lateral sclerosis. J. Ultrastruct. Pathol. 2014;38:295&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pubmed">25079897</ArticleId></ArticleIdList></Reference><Reference><Citation>Chal J, et al. Generation of human muscle fibers and satellite-like cells from human pluripotent stem cells in vitro. Nat. Protoc. 2016;11:1833.</Citation><ArticleIdList><ArticleId IdType="pubmed">27583644</ArticleId></ArticleIdList></Reference><Reference><Citation>Brack AS, Rando TA. Tissue-specific stem cells: lessons from the skeletal muscle satellite cell. Cell Stem Cell. 2012;10:504&#x2013;514.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3348769</ArticleId><ArticleId IdType="pubmed">22560074</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig R, Woodhead JL. Structure and function of myosin filaments. Curr. Opin. Struct. Biol. 2006;16:204&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pubmed">16563742</ArticleId></ArticleIdList></Reference><Reference><Citation>Jean-Philippe L, Picchiarelli G, Dupuis L, Gonzalez De Aguilar J-L. The role of skeletal muscle in amyotrophic lateral sclerosis. Brain Pathol. 2016;26:227&#x2013;236.</Citation><ArticleIdList><ArticleId IdType="pubmed">26780251</ArticleId></ArticleIdList></Reference><Reference><Citation>Pansarasa O, Rossi D, Berardinelli A, Cereda C. Amyotrophic lateral sclerosis and skeletal muscle: an update. Mol. Neurobiol. 2013;49:984&#x2013;990.</Citation><ArticleIdList><ArticleId IdType="pubmed">24198230</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong M, Martin LJ. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum. Mol. Genet. 2010;19:2284&#x2013;2302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2865380</ArticleId><ArticleId IdType="pubmed">20223753</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo G, et al. Defective mitochondrial dynamics is an early event in skeletal muscle of an amyotrophic lateral sclerosis mouse model. PLoS ONE. 2013;8:e82112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3855744</ArticleId><ArticleId IdType="pubmed">24324755</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedemann FR, et al. Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J. Neurol Sci. 1998;156:65&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">9559989</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastow EL, et al. New links between sod1 and metabolic dysfunction from a yeast model of amyotrophic lateral sclerosis. J. Cell Sci. 2016;129:4118&#x2013;4129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5117206</ArticleId><ArticleId IdType="pubmed">27656112</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan W, Pasinelli P, Trotti D. Role of mitochondria in mutant sod1 linked amyotrophic lateral sclerosis. Biochim. Biophys. Acta. 2014;1842:1295&#x2013;1301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4074562</ArticleId><ArticleId IdType="pubmed">24568860</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xfc;ttemann M, et al. Regulation of oxidative phosphorylation, the mitochondrial membrane potential, and their role in human disease. J. Bioenerg. Biomembr. 2008;40:445.</Citation><ArticleIdList><ArticleId IdType="pubmed">18843528</ArticleId></ArticleIdList></Reference><Reference><Citation>Zorova L, et al. Functional significance of the mitochondrial membrane potential. Biochem. (Mosc) Suppl. Ser. A: Membr. Cell Biol. 2018;12:20&#x2013;26.</Citation></Reference><Reference><Citation>Morgan JE, Partridge TA. Muscle satellite cells. Int. J. Biochem. Cell Biol. 2003;35:1151&#x2013;1156.</Citation><ArticleIdList><ArticleId IdType="pubmed">12757751</ArticleId></ArticleIdList></Reference><Reference><Citation>Palma E, et al. Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy. Proc. Natl. Acad. Sci. USA. 2016;113:3060&#x2013;3065.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4801305</ArticleId><ArticleId IdType="pubmed">26929355</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha MC, Pousinha PA, Correia AM, Sebasti&#xe3;o AM, Ribeiro JA. Early changes of neuromuscular transmission in the SOD1 (G93A) mice model of ALS start long before motor symptoms onset. PLoS ONE. 2013;8:e73846.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3764017</ArticleId><ArticleId IdType="pubmed">24040091</ArticleId></ArticleIdList></Reference><Reference><Citation>Picchiarelli G, et al. FUS-mediated regulation of acetylcholine receptor transcription at neuromuscular junctions is compromised in amyotrophic lateral sclerosis. Nat. Neurosci. 2019;22:1793&#x2013;1805.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6858880</ArticleId><ArticleId IdType="pubmed">31591561</ArticleId></ArticleIdList></Reference><Reference><Citation>Derave W, et al. Skeletal muscle properties in a transgenic mouse model for amyotrophic lateral sclerosis: effects of creatine treatment. Neurobiol. Dis. 2003;13:264&#x2013;272.</Citation><ArticleIdList><ArticleId IdType="pubmed">12901841</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenzi J, et al. Differentiation of control and ALS mutant human iPSCs into functional skeletal muscle cells, a tool for the study of neuromuscolar diseases. Stem Cell Res. 2016;17:140&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5009183</ArticleId><ArticleId IdType="pubmed">27318155</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw C, Quinn A, Daniel E. Amyotrophic lateral sclerosis/motor neurone disease. In: Oliver D, Borasio GD, Johnston W, editors. Palliative Care in Amyotrophic Lateral Sclerosis: From Diagnosis to Bereavement. Oxford: Oxford Scholarship Online; 2014. p. 1.</Citation></Reference><Reference><Citation>Dobrowolny G, et al. Skeletal muscle is a primary target of sod1g93a-mediated toxicity. Cell Metab. 2008;8:425&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pubmed">19046573</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung MJ, Suh Y. Ultrastructural changes of mitochondria in the skeletal muscle of patients with amyotrophic lateral sclerosis. Ultrastruct. Pathol. 2002;26:3&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">12028652</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G, et al. Metabolic changes associated with muscle expression of SOD1G93A. Front. Physiol. 2018;9:831.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6048270</ArticleId><ArticleId IdType="pubmed">30042688</ArticleId></ArticleIdList></Reference><Reference><Citation>Tompa DR, Kadhirvel S. Far positioned ALS associated mutants of Cu/Zn SOD forms partially metallated, destabilized misfolding intermediates. Biochem. Biophys. Res. Commun. 2019;516:494&#x2013;499.</Citation><ArticleIdList><ArticleId IdType="pubmed">31230748</ArticleId></ArticleIdList></Reference><Reference><Citation>Palamiuc L, et al. A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO Mol. Med. 2015;7:526&#x2013;546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4492815</ArticleId><ArticleId IdType="pubmed">25820275</ArticleId></ArticleIdList></Reference><Reference><Citation>Baskin KK, Winders BR, Olson EN. Muscle as a &#x201c;mediator&#x201d; of systemic metabolism. Cell Metab. 2015;21:237&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4398026</ArticleId><ArticleId IdType="pubmed">25651178</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y-J, Fan D. Elimination rate of serum lactate is correlated with amyotrophic lateral sclerosis progression. Chin. Med. J. (Engl.) 2016;129:28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4797538</ArticleId><ArticleId IdType="pubmed">26712429</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavado A, et al. Evaluation of holistic treatment for ALS reveals possible mechanism and therapeutic potential. Int. J. Pharm. Pharm. Res. 2017;11:348&#x2013;374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6326589</ArticleId><ArticleId IdType="pubmed">30637316</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez JA, et al. Destabilization of apoprotein is insufficient to explain Cu, Zn-superoxide dismutase-linked ALS pathogenesis. Proc. Natl. Acad. Sci. USA. 2005;102:10516&#x2013;10521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1175580</ArticleId><ArticleId IdType="pubmed">16020530</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakhit R, Chakrabartty A. Structure, folding, and misfolding of Cu, Zn superoxide dismutase in amyotrophic lateral sclerosis. Biochim. Biophys. Acta. 2006;1762:1025&#x2013;1037.</Citation><ArticleIdList><ArticleId IdType="pubmed">16814528</ArticleId></ArticleIdList></Reference><Reference><Citation>Huai J, Zhang Z. Structural properties and interaction partners of familial ALS-associated SOD1 mutants. Front. Neurol. 2019;10:527.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6536575</ArticleId><ArticleId IdType="pubmed">31164862</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith AS, et al. Utilization of microscale silicon cantilevers to assess cellular contractile function in vitro. J. Vis. Exp. 2014;92:e51866.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4692411</ArticleId><ArticleId IdType="pubmed">25350792</ArticleId></ArticleIdList></Reference><Reference><Citation>McAleer CW, et al. Mechanistic investigation of adult myotube response to exercise and drug treatment in vitro using a multiplexed functional assay system. J. Appl. Physiol. 2014;1985(117):1398&#x2013;1405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4254839</ArticleId><ArticleId IdType="pubmed">25301895</ArticleId></ArticleIdList></Reference><Reference><Citation>Nozaki T, Nikai S, Okabe R, Nagahama K, Eto N. A novel in vitro model of sarcopenia using BubR1 hypomorphic C2C12 myoblasts. Cytotechnology. 2016;68:1705&#x2013;1715.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5023544</ArticleId><ArticleId IdType="pubmed">26464273</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiyama T, Kii I, Kudo A. Inactivation of Rho/ROCK signaling is crucial for the nuclear accumulation of FKHR and myoblast fusion. J. Biol. 2004;279:47311&#x2013;47319.</Citation><ArticleIdList><ArticleId IdType="pubmed">15322110</ArticleId></ArticleIdList></Reference><Reference><Citation>Han D-S, Yang W-S, Kao T-W. Dexamethasone treatment at the myoblast stage enhanced C2C12 myocyte differentiation. Int. J. Med. Sci. 2017;14:434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5441035</ArticleId><ArticleId IdType="pubmed">28539819</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;ri&#xe9; S, et al. Premature proliferative arrest of cricopharyngeal myoblasts in oculo-pharyngeal muscular dystrophy: therapeutic perspectives of autologous myoblast transplantation. Neuromuscul. Disord. 2006;16:770&#x2013;781.</Citation><ArticleIdList><ArticleId IdType="pubmed">17005403</ArticleId></ArticleIdList></Reference><Reference><Citation>Santhanam N, et al. Stem cell derived phenotypic human neuromuscular junction model for dose response evaluation of therapeutics. Biomaterials. 2018;166:64&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5866791</ArticleId><ArticleId IdType="pubmed">29547745</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson K, Das M, Wahl KJ, Colton RJ, Hickman JJ. Measurement of contractile stress generated by cultured muscle on silicon cantilevers. PLoS ONE. 2010;5:e11042. doi: 10.1371/journal.pone.0011042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0011042</ArticleId><ArticleId IdType="pmc">PMC2883552</ArticleId><ArticleId IdType="pubmed">20548775</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>